Literature DB >> 24221054

Anorectal malignant melanoma in a hemorrhoidal nodule: a diagnostic and therapeutic problem.

Georgi Tchernev1, Kristina Semkova, Stanislav Philipov, Radoswet Gornev, Julian Ananiev, Uwe Wollina.   

Abstract

Anorectal malignant melanoma (ARMM) is an extremely rare condition, often misdiagnosed and mistreated until development of metastatic disease. Clinical presentation mimicking hemorrhoids is a well-known pitfall. We present a male patient with hemorrhoidal nodules who was referred to the policlinic of dermatology for management of anal pruritus. A dark macule was detected over one of the hemorrhoidal nodules histologically verified as melanoma. Subsequent CT and PET/CT showed lymph nodes involvement and the patient underwent wide local excision (WSE) followed by abdominoperineal resection (APR). The rarity of ARMM does not allow for establishment of a validated staging system, placebo-controlled treatment trials and management guidelines adoption. The current treatment for the condition is surgical excision, using different techniques according to the stage of the disease and depth of invasion. The prognosis and overall survival are poor, but recent genetic studies give promising results for molecular targeting. Awareness for this disease is indispensable, as early recognition could result in improved survival and quality of life.

Entities:  

Mesh:

Year:  2013        PMID: 24221054     DOI: 10.1007/s10354-013-0248-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  14 in total

Review 1.  Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification.

Authors:  Claudius Falch; Alexander Stojadinovic; Claus Hann-von-Weyhern; Mladjan Protic; Aviram Nissan; Mark B Faries; Martin Daumer; Anton J Bilchik; Avital Itzhak; Björn L D M Brücher
Journal:  J Am Coll Surg       Date:  2013-05-19       Impact factor: 6.113

2.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 3.  Mucosal melanoma: a clinically and biologically unique disease entity.

Authors:  Richard D Carvajal; Sharon A Spencer; William Lydiatt
Journal:  J Natl Compr Canc Netw       Date:  2012-03       Impact factor: 11.908

4.  c-kit gene mutation and CD117 expression in human anorectal melanomas.

Authors:  Shujuan Ni; Dan Huang; Xiaochen Chen; Jiaying Huang; Yunyi Kong; Ye Xu; Xiang Du; Weiqi Sheng
Journal:  Hum Pathol       Date:  2011-12-09       Impact factor: 3.466

Review 5.  Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma?

Authors:  John T Droesch; David R Flum; Gary N Mann
Journal:  Am J Surg       Date:  2005-04       Impact factor: 2.565

6.  Anorectal melanoma in The Netherlands: a report of 63 patients.

Authors:  R M Roumen
Journal:  Eur J Surg Oncol       Date:  1996-12       Impact factor: 4.424

7.  Locoregional lymphadenectomy in the surgical management of anorectal melanoma.

Authors:  Daniel R Perez; Atthaphorn Trakarnsanga; Jinru Shia; Garrett M Nash; Larissa K Temple; Philip B Paty; Jose G Guillem; Julio Garcia-Aguilar; Danielle Bello; Charlotte Ariyan; Richard D Carvajal; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2013-01-18       Impact factor: 5.344

8.  Surgical treatment of anorectal melanomas.

Authors:  B Siegal; D Cohen; E T Jacob
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

9.  Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years.

Authors:  Boel K Ragnarsson-Olding; Per J Nilsson; Lars B Olding; Bo R Nilsson
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

10.  Anorectal melanoma: surgical management guidelines according to tumour thickness.

Authors:  G H Weyandt; A O Eggert; M Houf; F Raulf; E B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.